RARE Chart
- 52-Week Range: $47.00 - $103.54
- Market Capitalization: $3.40B
- Short Percentage: 0%
- Target Price: $128.81
- Shares Outstanding: 69.93M
- Next Earnings: Feb 10
Catalysts
CategoryCatalyst
Earnings
RARE released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Ultragenyx Pharmaceutical Inc. (RARE) CEO Emil Kakkis on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 10th
- Ultragenyx Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate UpdateGlobeNewsWire | February 10th
- Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire | February 2nd
- Ultragenyx to Present at H.C. Wainwright BioConnect Healthcare ConferenceGlobeNewsWire | January 6th
- 5 Sizzling ‘Strong Buy' Analyst Biotechnology Picks for 202224/7 Wall Street | January 4th
Company Info
Website: https://www.ultragenyx.com
Address: 60 Leveroni Court, Novato, CA, United States, 94949
Sector: Healthcare
Industry: Biotechnology
Full time employees: 1,119
Address: 60 Leveroni Court, Novato, CA, United States, 94949
Sector: Healthcare
Industry: Biotechnology
Full time employees: 1,119
$RARE soon
$RARE good times
$RARE dont be a POS today
$RARE hows short doing? Keep short pls
we need your money.
$RARE Lol she wants higher
$RARE holy fuck
$RARE starting to gap up a little
$RARE man this will be good in coming weeks
$RARE ready to explode
$RARE hold